Preliminary studies indicate that certain coumarins, such as esculetin, may counteract tumor-induced NK cell dysfunction by inhibiting the TGF-β signaling pathway, thereby suppressing tumor cell proliferation, inducing apoptosis, and enhancing immune responses (69–71). This evidence concerns the gene TGFB1 and neoplasm.